AXIAL THERAPEUTICS, INC.

Description: Class 1: Chemicals, biochemicals, cells, and microbes for use in the manufacture of probiotic, microbe-targeted, or host-targeted pharmaceutical preparations, for in vitro and in vivo scientific or research use, and for use in industry and science; Chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes for the manufacture of probiotic, microbe-targeted, or host-targeted pharmaceutical preparations for the treatment, prevention, and detection of nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, and gastrointestinal and immunological diseases
Class 5: Probiotic, microbe-targeted, or host-targeted pharmaceutical preparations and substances for the treatment, prevention, and detection of nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases; Chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes being pharmaceutical preparations and substances for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, and gastrointestinal and immunological diseases
Class 42: Providing medical research and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; drug discovery services; pharmaceutical research; research and development of new probiotic, microbe-targeted, or host-targeted phamaceutical products; research in the fields of biochemistry, biotechnology, and conducting clinical trials for others
Class 44: Providing medical information in the fields of diagnostic, prophylactic, and therapeutic properties of probiotic, microbe-targeted, or host-targeted pharmaceuticals

Description: Class 1: Chemicals, biochemicals, cells, and microbes for use in the manufacture of probiotic, microbe-targeted, or host-targeted pharmaceutical preparations, for in vitro and in vivo scientific or research use, and for use in industry and science; Chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes for the manufacture of probiotic, microbe-targeted, or host-targeted pharmaceutical preparations for the treatment, prevention, and detection of nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, and gastrointestinal and immunological diseases
Class 5: Probiotic, microbe-targeted, or host-targeted pharmaceutical preparations and substances for the treatment, prevention, and detection of nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases; Chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes being pharmaceutical preparations and substances for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, and gastrointestinal and immunological diseases
Class 42: Providing medical research and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; drug discovery services; pharmaceutical research; research and development of new probiotic, microbe-targeted, or host-targeted phamaceutical products; research in the fields of biochemistry, biotechnology, and conducting clinical trials for others
Class 44: Providing medical information in the fields of diagnostic, prophylactic, and therapeutic properties of probiotic, microbe-targeted, or host-targeted pharmaceuticals

Description: Probiotic, microbe-targeted, or host-targeted pharmaceutical preparations and substances for the treatment, prevention, and detection of nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases; Chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes being pharmaceutical preparations and substances for the treatment, prevention, and detection of nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, and gastrointestinal and immunological diseases; Chemicals, biochemicals, cells, and microbes for use in the manufacture of probiotic, microbe-targeted, or host-targeted pharmaceutical preparations, for in vitro and in vivo scientific or research use, and for use in industry and science; Chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes for the manufacture of probiotic, microbe-targeted, or host-targeted pharmaceutical preparations for the treatment, prevention, and detection of nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, and gastrointestinal and immunological diseases; Providing medical information in the fields of diagnostic, prophylactic, and therapeutic properties of probiotic, microbe-targeted, or host-targeted pharmaceuticals; Providing medical research and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; drug discovery services; pharmaceutical research; research in the fields of biochemistry, biotechnology, and conducting clinical trials for others; research and development of new probiotic, microbe-targeted, or host-targeted pharmaceutical products

Description: Probiotic, microbe-targeted, or host-targeted pharmaceutical preparations and substances for the treatment, prevention, and detection of nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases; Chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes being pharmaceutical preparations and substances for the treatment, prevention, and detection of nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, and gastrointestinal and immunological diseases; Chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes for the manufacture of probiotic, microbe-targeted, or host-targeted pharmaceutical preparations for the treatment, prevention, and detection of nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, and gastrointestinal and immunological diseases; Chemicals, biochemicals, cells, and microbes for use in the manufacture of probiotic, microbe-targeted, or host-targeted pharmaceutical preparations, for in vitro and in vivo scientific or research use, and for use in industry and science; Providing medical information in the fields of diagnostic, prophylactic, and therapeutic properties of probiotic, microbe-targeted, or host-targeted pharmaceuticals; Providing medical research and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; drug discovery services; pharmaceutical research; research and development of new probiotic, microbe-targeted, or host-targeted pharmaceutical products; research in the fields of biochemistry, biotechnology, and conducting clinical trials for others

Description: Class 1: Chemicals, biochemicals, cells, and microbes for use in the manufacture of probiotic or microbe-targeted pharmaceutical preparations, for in vitro and in vivo scientific or research use, and for use in industry and science; chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes for the manufacture of probiotic or microbe-targeted pharmaceutical preparations for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids
Class 5: Probiotic or microbe-targeted pharmaceutical preparations and substances for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids; chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes being pharmaceutical preparations and substances for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids
Class 42: Providing medical and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; drug discovery services; pharmaceutical research; research and development of new probiotic or microbe-targeted phamaceutical products; research in the fields of biochemistry, biotechnology, and conducting clinical trials for others
Class 44: Providing medical information in the fields of diagnostic, prophylactic, and therapeutic properties of probiotic or microbe-targeted pharmaceuticals

Description: Class 1: Chemicals, biochemicals, cells, and microbes for use in the manufacture of probiotic or microbe-targeted pharmaceutical preparations, for in vitro and in vivo scientific or research use, and for use in industry and science; chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes for the manufacture of probiotic or microbe-targeted pharmaceutical preparations for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids
Class 5: Probiotic or microbe-targeted pharmaceutical preparations and substances for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids; chemical, biochemical and microbial products, namely, one or more of small molecules, proteins, antibodies, nucleic acids, probiotic bacteria, probiotic bacterial cultures, and microbes being pharmaceutical preparations and substances for the treatment, prevention, and detection of central nervous system diseases and disorders, cancer, tumors, fibrosis, inflammation, microbe-related and microbiome-related conditions, gastrointestinal and immunological diseases, and any disease or disorder associated with intestinal permeability, or leaky gut, and amyloids
Class 42: Providing medical and scientific research information in the fields of pharmaceuticals, biochemistry, biotechnology, and clinical trials; drug discovery services; pharmaceutical research; research and development of new probiotic or microbe-targeted phamaceutical products; research in the fields of biochemistry, biotechnology, and conducting clinical trials for others
Class 44: Providing medical information in the fields of diagnostic, prophylactic, and therapeutic properties of probiotic or microbe-targeted pharmaceuticals

Description: Chemical or biochemical products, namely, small molecules, probiotic bacteria, probiotic bacterial cultures, and/or microbes for the treatment of gastrointestinal diseases, microbiome related conditions, central nervous system diseases and disorders, and/or any disease or disorder associated with leaky gut; microbes, chemicals and/or biochemicals for use in the manufacture of pharmaceutical preparations, probiotic supplements, and/or nutritional supplements; probiotic bacteria, probiotic bacterial cultures, and/or biochemicals for in vitro scientific or research use

Description: Class 1: Microbes for use in the manufacture of probiotic supplements; probiotic bacteria and probiotic bacterial cultures; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Chemical, biochemical and biotechnological preparations used in industry and science, namely, antibodies and fragments of antibodies for use in the manufacture of pharmaceutical preparations; Chemical products, namely, small molecules for the treatment of gastrointestinal diseases, microbiome related conditions, central nervous system diseases and disorders, or any disease or disorder associated with leaky gut
Class 5: Probiotic or microbe-targeted pharmaceutical preparations and substances for the treatment of gastrointestinal diseases, microbiome related conditions, central nervous system diseases and disorders, or any disease or disorder associated with leaky gut

Description: Class 1: Microbes for use in the manufacture of probiotic supplements; probiotic bacteria and probiotic bacterial cultures; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Chemical, biochemical and biotechnological preparations used in industry and science, namely, antibodies and fragments of antibodies for use in the manufacture of pharmaceutical preparations; Chemical products, namely, small molecules for the treatment of gastrointestinal diseases, microbiome related conditions, central nervous system diseases and disorders, or any disease or disorder associated with leaky gut
Class 5: Probiotic or microbe-targeted pharmaceutical preparations and substances for the treatment of gastrointestinal diseases, microbiome related conditions, central nervous system diseases and disorders, or any disease or disorder associated with leaky gut